Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Neurosci ; 43(1): 56-67, 2023 01 04.
Article in English | MEDLINE | ID: mdl-36400530

ABSTRACT

In rodents, cortical information is transferred to the substantia nigra pars reticulata (SNr) through motor and medial prefrontal (mPF) basal ganglia (BG) circuits implicated in motor and cognitive/motivational behaviors, respectively. The serotonergic 5-HT2A receptors are located in both of these neuronal networks, displaying topographical differences with a high expression in the associative/limbic territories, and a very low expression in the subthalamic nucleus. This study investigated whether the stimulation of 5-HT2A receptors could have a specific signature on the dynamic regulation of BG circuits, preferentially modulating the mPF information processing through trans-striatal pathways. We performed in vivo single-unit extracellular recordings to assess the effect of the 5-HT2A agonist TCB-2 on the spontaneous and cortically evoked activity of lateral and medial SNr neurons in male rats (involved in motor and mPF circuits, respectively). TCB-2 (50-200 µg/kg, i.v.) increased the basal firing rate and enhanced the cortically evoked inhibitory response of medial SNr neurons (transmission through the direct striato-nigral pathway). A prior administration of the preferential 5-HT2A receptor antagonist MDL11939 (200 µg/kg, i.v.) did not modify any electrophysiological parameter, but occluded TCB-2-induced effects. In animals treated with the 5-HT synthesis inhibitor pCPA (4-chloro-dl-phenylalanine methyl ester hydrochloride), TCB-2 failed to induce the above-mentioned effects, thus suggesting the contribution of endogenous 5-HT. However, the mobilization of 5-HT induced by the acute administration of fluoxetine (10 mg/kg, i.p.) did not mimic the effects triggered by TCB-2. Overall, these data suggest that 5-HT2A receptors have a preferential modulatory action on the dynamic regulation of BG circuitry.SIGNIFICANCE STATEMENT Motor and medial prefrontal (mPF) basal ganglia (BG) circuits play an important role in integrative brain functions like movement control or cognitive/motivational behavior, respectively. Although these neuronal networks express 5-HT2A receptors, the expression is higher in associative/limbic structures than in the motor ones. We show a topographical-dependent dissociation in the effects triggered by the 5HT2A agonist TCB-2, which specifically increases the medial substantia nigra pars reticulata neuron activity and has a preferential action on mPF information processing through the striato-nigral direct pathway. These are very likely to be 5-HT2A receptor-mediated effects that require mobilization of the endogenous 5-HT system. These findings provide evidence about the specific signature of 5-HT2A receptors on the dynamic regulation of BG circuits.


Subject(s)
Receptor, Serotonin, 5-HT2A , Serotonin , Rats , Male , Animals , Serotonin/metabolism , Receptor, Serotonin, 5-HT2A/metabolism , Rats, Sprague-Dawley , Basal Ganglia/physiology , Corpus Striatum/physiology , Substantia Nigra/metabolism
2.
Nat Rev Neurosci ; 23(4): 191-203, 2022 04.
Article in English | MEDLINE | ID: mdl-35228740

ABSTRACT

Central nervous system neurons communicate via fast synaptic transmission mediated by ligand-gated ion channel (LGIC) receptors and slower neuromodulation mediated by G protein-coupled receptors (GPCRs). These receptors influence many neuronal functions, including presynaptic neurotransmitter release. Presynaptic LGIC and GPCR activation by locally released neurotransmitters influences neuronal communication in ways that modify effects of somatic action potentials. Although much is known about presynaptic receptors and their mechanisms of action, less is known about when and where these receptor actions alter release, especially in vivo. This Review focuses on emerging evidence for important local presynaptic receptor actions and ideas for future studies in this area.


Subject(s)
Cell Communication , Receptors, Presynaptic , Action Potentials , Humans , Neurons , Synaptic Transmission
3.
Neurobiol Dis ; 148: 105214, 2021 01.
Article in English | MEDLINE | ID: mdl-33278598

ABSTRACT

The basal ganglia (BG) are involved in cognitive/motivational functions in addition to movement control. Thus, BG segregated circuits, the sensorimotor (SM) and medial prefrontal (mPF) circuits, process different functional domains, such as motor and cognitive/motivational behaviours, respectively. With a high presence in the BG, the CB1 cannabinoid receptor modulates BG circuits. Furthermore, dopamine (DA), one of the principal neurotransmitters in the BG, also plays a key role in circuit functionality. Taking into account the interaction between DA and the endocannabinoid system at the BG level, we investigated the functioning of BG circuits and their modulation by the CB1 receptor under DA-depleted conditions. We performed single-unit extracellular recordings of substantia nigra pars reticulata (SNr) neurons with simultaneous cortical stimulation in sham and 6-hydroxydopamine (6-OHDA)-lesioned rats, together with immunohistochemical assays. We showed that DA loss alters cortico-nigral information processing in both circuits, with a predominant transmission through the hyperdirect pathway in the SM circuit and an increased transmission through the direct pathway in the mPF circuit. Moreover, although DA denervation does not change CB1 receptor density, it impairs its functionality, leading to a lack of modulation. These data highlight an abnormal transfer of information through the associative/limbic domains after DA denervation that may be related to the non-motor symptoms manifested by Parkinson's disease patients.


Subject(s)
Basal Ganglia/metabolism , Dopamine/metabolism , Limbic System/metabolism , Motor Cortex/metabolism , Neurons/metabolism , Pars Reticulata/metabolism , Receptor, Cannabinoid, CB1/metabolism , Action Potentials/physiology , Animals , Basal Ganglia/drug effects , Disease Models, Animal , Electrodes , Immunohistochemistry , Limbic System/drug effects , Male , Motor Cortex/drug effects , Neural Pathways/drug effects , Neural Pathways/metabolism , Neurons/drug effects , Oxidopamine/toxicity , Parkinson Disease/metabolism , Pars Reticulata/cytology , Pars Reticulata/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Receptor, Cannabinoid, CB1/physiology , Sympathectomy, Chemical , Sympatholytics/toxicity
4.
Int Rev Neurobiol ; 146: 229-257, 2019.
Article in English | MEDLINE | ID: mdl-31349929

ABSTRACT

The basal ganglia (BG), an organized network of nuclei that integrates cortical information, play a crucial role in controlling motor function. In fact, movement disorders such as Parkinson's disease (PD) and Huntington's disease (HD) are caused by the degeneration of specific structures within the BG. There is substantial evidence supporting the idea that cannabinoids may constitute novel promising compounds for the treatment of movement disorders as neuroprotective and anti-inflammatory agents. This potential therapeutic role of cannabinoids is based, among other qualities, on their capacity to reduce oxidative injury and excitotoxicity, control calcium influx and limit the toxicity of reactive microglia. The mechanisms involved in these effects are related to CB1 and CB2 receptor activation, although some of the effects are CB receptor independent. Thus, taking into account the aforementioned properties, compounds that act on the endocannabinoid system could be useful as a basis for developing disease-modifying therapies for PD and HD.


Subject(s)
Cannabinoids/therapeutic use , Endocannabinoids/physiology , Huntington Disease/drug therapy , Neuroprotective Agents/therapeutic use , Parkinson Disease/drug therapy , Animals , Basal Ganglia/pathology , Basal Ganglia/physiology , Cannabinoids/pharmacology , Endocannabinoids/therapeutic use , Humans , Huntington Disease/pathology , Neuroprotective Agents/pharmacology , Parkinson Disease/pathology
5.
Br J Pharmacol ; 176(8): 1156-1169, 2019 04.
Article in English | MEDLINE | ID: mdl-30735570

ABSTRACT

BACKGROUND AND PURPOSE: In the sensorimotor (SM) and medial prefrontal (mPF) basal ganglia (BG) circuits, the cortical information is transferred to the substantia nigra pars reticulata (SNr) through the hyperdirect trans-subthalamic pathway and through the direct and indirect trans-striatal pathways. The cannabinoid CB1 receptor, which is highly expressed in both BG circuits, may participate in the regulation of motor and motivational behaviours. Here, we investigated the modulation of cortico-nigral information transmission through the BG circuits by cannabinoids. EXPERIMENTAL APPROACH: We used single-unit recordings of SNr neurons along with simultaneous electrical stimulation of motor or mPF cortex in anaesthetized rats. KEY RESULTS: Cortical stimulation elicited a triphasic response in the SNr neurons from both SM and mPF-BG circuits, which consisted of an early excitation (hyperdirect transmission pathway), an inhibition (direct transmission pathway), and a late excitation (indirect transmission pathway). In the SM circuit, after Δ9 -tetrahydrocannabinol or WIN 55,212-2 administration, the inhibition and the late excitation were decreased or completely lost, whereas the early excitation response remained unaltered. However, cannabinoid administration dramatically decreased all the responses in the mPF circuit. The CB1 receptor antagonist AM251 (2 mg·kg-1 , i.v.) did not modify the triphasic response, but blocked the effects induced by cannabinoid agonists. CONCLUSIONS AND IMPLICATIONS: CB1 receptor activation modulates the SM information transmission through the trans-striatal pathways and profoundly decreases the cortico-BG transmission through the mPF circuit. These results may be relevant for elucidating the involvement of the cannabinoid system in motor performance and in decision making or goal-directed behaviour.


Subject(s)
Basal Ganglia/drug effects , Cannabinoids/pharmacology , Nerve Net/drug effects , Prefrontal Cortex/drug effects , Sensorimotor Cortex/drug effects , Animals , Basal Ganglia/physiology , Male , Nerve Net/physiology , Prefrontal Cortex/physiology , Rats , Rats, Sprague-Dawley , Sensorimotor Cortex/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...